Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL

Clinical trial NCT01527422 · COMPLETED

Trial details

NCT number: NCT01527422
Sponsor: Fernando Cabanillas
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma Non Hodgkin's Lymphoma

Start date: 2006-01-01
Primary completion: 2010-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.